Assessing Naltrexone Prescribing and Barriers to Initiation for Alcohol Use Disorder: A Multidisciplinary, Multisite Survey

ObjectiveTo survey barriers in prescribing naltrexone for alcohol use disorder.MethodsA 12-question survey related to naltrexone prescribing patterns, perceptions, and knowledge was sent to 770 prescribers in the departments of internal medicine, family medicine, and psychiatry across a health syste...

Full description

Bibliographic Details
Main Authors: Jonathan G. Leung, Prasanna P. Narayanan, Matej Markota, Nathaniel E. Miller, Kemuel L. Philbrick, M. Caroline Burton, Robert W. Kirchoff
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-05-01
Series:Frontiers in Psychiatry
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fpsyt.2022.856938/full
_version_ 1811309352310538240
author Jonathan G. Leung
Prasanna P. Narayanan
Matej Markota
Nathaniel E. Miller
Kemuel L. Philbrick
M. Caroline Burton
Robert W. Kirchoff
author_facet Jonathan G. Leung
Prasanna P. Narayanan
Matej Markota
Nathaniel E. Miller
Kemuel L. Philbrick
M. Caroline Burton
Robert W. Kirchoff
author_sort Jonathan G. Leung
collection DOAJ
description ObjectiveTo survey barriers in prescribing naltrexone for alcohol use disorder.MethodsA 12-question survey related to naltrexone prescribing patterns, perceptions, and knowledge was sent to 770 prescribers in the departments of internal medicine, family medicine, and psychiatry across a health system with sites in Arizona, Florida, and Minnesota.ResultsResponses were obtained and included for 146/770 prescribers (19.0% response rate). Most respondents were in the department of internal medicine (n = 94, 64.4%), but the departments of psychiatry (n = 22, 15.1%) and family medicine (n = 30, 20.5%) were also represented. Only 34 (23.3%) respondents indicated they had prescribed naltrexone in the previous 3 months. The most common reasons for not prescribing naltrexone were “unfamiliarity with naltrexone for treatment of alcohol use disorder” and “patients do not have appropriate follow-up or are not in a formal treatment program.” Compared with those representing internal/family medicine, psychiatry respondents were more likely to prescribe naltrexone and answer knowledge questions correctly.ConclusionIn this survey among primarily non-addiction-trained prescribers, a disparity was shown for prescribing naltrexone and in knowledge barriers between staff in internal/family medicine and psychiatry. There exist opportunities for education and quality improvement that promote the prescribing of naltrexone for alcohol use disorder by non-addiction specialists.
first_indexed 2024-04-13T09:40:44Z
format Article
id doaj.art-2b742d5323e446baa5f40ad6c033bf77
institution Directory Open Access Journal
issn 1664-0640
language English
last_indexed 2024-04-13T09:40:44Z
publishDate 2022-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Psychiatry
spelling doaj.art-2b742d5323e446baa5f40ad6c033bf772022-12-22T02:51:56ZengFrontiers Media S.A.Frontiers in Psychiatry1664-06402022-05-011310.3389/fpsyt.2022.856938856938Assessing Naltrexone Prescribing and Barriers to Initiation for Alcohol Use Disorder: A Multidisciplinary, Multisite SurveyJonathan G. Leung0Prasanna P. Narayanan1Matej Markota2Nathaniel E. Miller3Kemuel L. Philbrick4M. Caroline Burton5Robert W. Kirchoff6Pharmacy Services, Mayo Clinic, Rochester, MN, United StatesPharmacy Services, Mayo Clinic, Rochester, MN, United StatesDepartment of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, United StatesMayo Family Clinic Kasson, Kasson, MN, United StatesDepartment of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, United StatesDivision of Hospital Internal Medicine, Mayo Clinic, Rochester, MN, United StatesDivision of Hospital Internal Medicine, Mayo Clinic, Rochester, MN, United StatesObjectiveTo survey barriers in prescribing naltrexone for alcohol use disorder.MethodsA 12-question survey related to naltrexone prescribing patterns, perceptions, and knowledge was sent to 770 prescribers in the departments of internal medicine, family medicine, and psychiatry across a health system with sites in Arizona, Florida, and Minnesota.ResultsResponses were obtained and included for 146/770 prescribers (19.0% response rate). Most respondents were in the department of internal medicine (n = 94, 64.4%), but the departments of psychiatry (n = 22, 15.1%) and family medicine (n = 30, 20.5%) were also represented. Only 34 (23.3%) respondents indicated they had prescribed naltrexone in the previous 3 months. The most common reasons for not prescribing naltrexone were “unfamiliarity with naltrexone for treatment of alcohol use disorder” and “patients do not have appropriate follow-up or are not in a formal treatment program.” Compared with those representing internal/family medicine, psychiatry respondents were more likely to prescribe naltrexone and answer knowledge questions correctly.ConclusionIn this survey among primarily non-addiction-trained prescribers, a disparity was shown for prescribing naltrexone and in knowledge barriers between staff in internal/family medicine and psychiatry. There exist opportunities for education and quality improvement that promote the prescribing of naltrexone for alcohol use disorder by non-addiction specialists.https://www.frontiersin.org/articles/10.3389/fpsyt.2022.856938/fullalcohol use disordernaltrexoneprescribingsubstance use disordersurvey
spellingShingle Jonathan G. Leung
Prasanna P. Narayanan
Matej Markota
Nathaniel E. Miller
Kemuel L. Philbrick
M. Caroline Burton
Robert W. Kirchoff
Assessing Naltrexone Prescribing and Barriers to Initiation for Alcohol Use Disorder: A Multidisciplinary, Multisite Survey
Frontiers in Psychiatry
alcohol use disorder
naltrexone
prescribing
substance use disorder
survey
title Assessing Naltrexone Prescribing and Barriers to Initiation for Alcohol Use Disorder: A Multidisciplinary, Multisite Survey
title_full Assessing Naltrexone Prescribing and Barriers to Initiation for Alcohol Use Disorder: A Multidisciplinary, Multisite Survey
title_fullStr Assessing Naltrexone Prescribing and Barriers to Initiation for Alcohol Use Disorder: A Multidisciplinary, Multisite Survey
title_full_unstemmed Assessing Naltrexone Prescribing and Barriers to Initiation for Alcohol Use Disorder: A Multidisciplinary, Multisite Survey
title_short Assessing Naltrexone Prescribing and Barriers to Initiation for Alcohol Use Disorder: A Multidisciplinary, Multisite Survey
title_sort assessing naltrexone prescribing and barriers to initiation for alcohol use disorder a multidisciplinary multisite survey
topic alcohol use disorder
naltrexone
prescribing
substance use disorder
survey
url https://www.frontiersin.org/articles/10.3389/fpsyt.2022.856938/full
work_keys_str_mv AT jonathangleung assessingnaltrexoneprescribingandbarrierstoinitiationforalcoholusedisorderamultidisciplinarymultisitesurvey
AT prasannapnarayanan assessingnaltrexoneprescribingandbarrierstoinitiationforalcoholusedisorderamultidisciplinarymultisitesurvey
AT matejmarkota assessingnaltrexoneprescribingandbarrierstoinitiationforalcoholusedisorderamultidisciplinarymultisitesurvey
AT nathanielemiller assessingnaltrexoneprescribingandbarrierstoinitiationforalcoholusedisorderamultidisciplinarymultisitesurvey
AT kemuellphilbrick assessingnaltrexoneprescribingandbarrierstoinitiationforalcoholusedisorderamultidisciplinarymultisitesurvey
AT mcarolineburton assessingnaltrexoneprescribingandbarrierstoinitiationforalcoholusedisorderamultidisciplinarymultisitesurvey
AT robertwkirchoff assessingnaltrexoneprescribingandbarrierstoinitiationforalcoholusedisorderamultidisciplinarymultisitesurvey